ストックスクリーナーアプリを入手
312.05
0.38%
1.19
プレマーケット:
312.54
0.49
+0.16%
Cigna Group (CI) 最新ニュース
The Cigna Group (CI): A Bull Case Theory - Insider Monkey
Express Scripts sues to block Arkansas law barring PBM ownership of pharmacies - marketscreener.com
Cigna study: High health insurance literacy associated with improved vitality, work productivity, and health outcomes - The Business Journals
The Cigna Group (NYSE:CI) Passed Our Checks, And It's About To Pay A US$1.51 Dividend - simplywall.st
Why You Might Be Interested In The Cigna Group (NYSE:CI) For Its Upcoming Dividend - Yahoo Finance
2 Reasons to Like CI and 1 to Stay Skeptical - FinancialContent
CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now? - Yahoo Finance
The Zacks Analyst Blog Highlights Costco Wholesale, Chubb, Cigna, Global Self Storage and Natural Health Trends - Yahoo Finance
Cigna’s SWOT analysis: stock poised for growth amid healthcare challenges - Investing.com
UBS Maintains Buy Rating on Cigna (CI) Stock - Insider Monkey
Molson Coors and Cigna Head My “Do Nothing” Stock List - TribLIVE.com
UBS maintains Cigna stock Buy rating with $390 target - Investing.com
Top Research Reports for Costco, Chubb & Cigna - Yahoo Finance
Guggenheim Reiterates Buy Rating for Cigna Group (CI) with $388 Price Target | CI Stock News - GuruFocus
Cigna Adds Kerecis Intact Fish-Skin Grafts to Coverage Policy - Business Wire
Cigna's (CI) Evernorth Secures Open Access for Key Products | CI Stock News - GuruFocus
Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo Nordisk Weight Loss Drugs - MSN
FTC Scraps PepsiCo Price Discrimination Case In 3-0 Vote, Marking Major Shift As Trump-Era Leadership Reverses Biden CrackdownCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Cigna is putting a cap on weight loss drug costs - Yahoo Finance
Cigna (CI) Caps Out-of-Pocket Costs on Weight-Loss Drugs for Pat - GuruFocus
Cigna (CI) Caps Out-of-Pocket Costs on Weight-Loss Drugs for Patients | CI Stock News - GuruFocus
Cigna (CI) Expands Access to Weight Loss Medications with New Ph - GuruFocus
Cigna (CI) Unit Launches Cost-Effective Pharmacy Benefit for Wei - GuruFocus
Cigna (CI) Launches Cost-Effective Benefit Option for Weight Loss Drugs | CI Stock News - GuruFocus
Cigna (CI) Caps Weight-Loss Drug Costs, Impact on Telehealth Offerings | CI Stock News - GuruFocus
Former employees sue Cigna's 401(k) fiduciaries for misusing forfeited employer match money - Pensions & Investments
Pharmalittle: We're reading about rising drug prices, Cigna's plan for weight loss drugs, and more - statnews.com
Cigna to offer $200 Wegovy, Zepbound weight-loss benefit - Reuters
Cigna (CI) Launches Cost-Capping Program for Weight-Loss Drugs - GuruFocus
Cigna’s Evernorth caps weight-loss drug copays at $200/month (CI:NYSE) - Seeking Alpha
Cigna Offers New Weight-Loss Drug Pricing Plan to Boost Use - Bloomberg
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs - MSN
Cigna (CI) Faces Increased Scrutiny Amid Expanded Medicare Audits | CI Stock News - GuruFocus
Cigna Group's Evernorth Launches Benefit Option to Lower Weight Loss Medicine Costs - marketscreener.com
Cigna (CI) Affected by Medicare Advantage Audit Expansion | CI Stock News - GuruFocus
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month - Quantisnow
Cigna Accused of Misusing Retirement Plan Funds - USA Herald
Baird Adjusts Price Target on Cigna Group to $364 From $362, Maintains Outperform Rating - marketscreener.com
Cigna Accused Of Mismanaging Retirement Plan Funds - Law360
2nd Circ. Affirms Dismissal Of Lab's Payment Suit Against Cigna - Law360
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years - Benzinga
Cigna Group (CI) Reaffirms 2025 Financial Outlook - GuruFocus
Cigna Reaffirms 2025 Earnings Projection Amid Investor Meetings - TipRanks
Virtual-Care Company Omada Files IPO Papers - Healthcare Innovation
Forfeiture Lawsuit Filed Against Cigna; Intuit Reaches Settlement - planadviser
Cigna employees file a 401(k) lawsuit, alleging misuse of forfeited funds - BenefitsPRO
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
The Cigna Group Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Cigna Hit With Forfeiture Lawsuit; Intuit Reaches Settlement - plansponsor
Trump’s Drug Pricing Order Targets PBMs—Pharma Stocks May Escape the Worst - Investing.com
CI Q1 Earnings Call: Cigna Delivers Revenue Beat and Focuses on Healthcare Innovation - Yahoo Finance
0.68%
大文字化:
|
ボリューム (24 時間):